External Infusion Pumps
National · Effective Jan 25, 2026
1 active Medicare policy lists J9370, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Jan 25, 2026
6 policies from 6 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J9370 |
|---|---|---|
| Post-Herpetic Neuralgia | Feb 20, 2024 | Covered |
| Policy | Effective | Status of J9370 |
|---|---|---|
| MARQIBO (VINCRISTINE SULFATE LIPOSOME) (RETIRED AS OF 02/02/2023) | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J9370 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9370 |
|---|---|---|
| Q3 - 2026 Jefferson Health Plans MedOnc Master Drug List | Not recorded | Prior auth required |
| Policy | Effective | Status of J9370 |
|---|---|---|
| Marqibo (Vincristine Sulfate Liposome Injection) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9370 |
|---|---|---|
| Marqibo (vincristine sulfate liposomal) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |